SLXNW Financials

Biomotion Sciences Warrant - Financial statements & key metrics

Stock Price

$0.01

Market Cap

P/E Ratio

0.0

EPS

$26.36

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-16.52M

EPS (Diluted)

$26.36

Balance Sheet Highlights

Total Assets

$2.86M

Total Liabilities

$6.85M

Shareholders Equity

Cash & Equivalents

$1.19M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-8.40M

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is SLXNW revenue?

View SLXNW's income statement for detailed revenue data.

Is SLXNW profitable?

SLXNW reported a loss of $16.52M in the most recent quarter.

What is SLXNW market cap?

Market cap data for SLXNW is available above.

Does SLXNW have debt?

View SLXNW's balance sheet for debt information.

What is SLXNW cash flow?

Cash flow data is available in the full financial statements.